Perrigo Q3 net sales rise 24%
The company has posted a net income of $89.09m for the third quarter 2011, or $0.95 per diluted share, compared to net income of $62.18m, or $0.67 per
Biologics contract development and manufacturing organisation (CDMO) AsymBio is set to secure 1.2397bn yuan (approximately $184m) from Asymchem Group, Hillhouse Qirui and other investors to support its long-term growth.